Aspect Biosystems picks up Series A

Vancouver, British Columbia-based Aspect Biosystems, a biotechnology company, has raised US$20 million in Series A financing.

Vancouver, British Columbia-based Aspect Biosystems, a biotechnology company, has raised US$20 million in Series A financing. Radical Ventures led the round with participation from other backers that included Pangaea Ventures, Pallasite Ventures, and Rhino Ventures. The capital infusion will be used to advance Aspect’s multiple tissue therapeutic programs, expand its technology platform capabilities and grow its team.

Source: Press Release